Estradiol/Norethindrone Acetate

้›ŒไบŒ้†‡/้†‹็‚”่ฏบ้…ฎ

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEstradiol/Norethindrone Acetate
Drug Alias NameEstradiol and Norethindrone Acetate้›ŒไบŒ้†‡้†‹็‚”่ฏบ้…ฎ้›ŒไบŒ้†‡้†‹้…ธ็‚”่ฏบ้…ฎ่ƒถๅ›ŠEstradiol - norethindrone acetate mixtEstradiol - norethisterone acetate mixt +[12]ย 
ClassificationSmall molecules > Steroids
Mechanisms of ActionEstrogen receptors agonistsProgesterone receptor agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsOestrogen deficiency symptomsVasomotor symptomVulvar and vaginal atrophy +[6]ย 
Global Approved IndicationsOestrogen deficiency symptomsVasomotor symptomVulvar and vaginal atrophy +[6]ย 
Approved Indications in ChinaOestrogen deficiency symptomsMenopausal symptomsOsteoporosis, Postmenopausal
Original Approved Country/TerritoryUnited States
Original Approved Date1998/08/07
Country/TerritoryBelgiumUnited StatesSweden +[13]ย 
CombinationsYes EstradiolNorethindrone Acetate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNoven Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAska Pharmaceutical Co LtdNoven Pharmaceuticals IncKunming Sinoway Natural Pharmaceuticals Co Ltd
Inactive CompaniesNovo Nordisk A/S
Active IndicationsOestrogen deficiency symptomsVasomotor symptomVulvar and vaginal atrophy +[6]ย 
Inactive IndicationsN/A

Other Information

ATC CodeG03
Related LinksWikipediaKEGG